Founder & CEO, Nevakar
Dr. Puri is a pharmacist by education, and a pharmaceutical business executive by training and experience. After earning his MS and PhD in Pharmaceutics, he worked for several years at Baxter Healthcare Corp and Amgen Inc., in the areas of parenteral drug development and drug delivery.
He founded InnoPharma in 2005 with a focus on developing complex generic pharmaceuticals of sterile injectable dosage forms. This business model was targeted to provide options to health care providers and patients for some of the products where no generic option was available, primarily attributed to complexity of developing and manufacturing the drug products.
Between 2005 and 2014, InnoPharma grew as a major player in generic injectable space, with numerous approved and filed products. InnoPharma was acquired by Pfizer in Sept 2014, and became an integral part of Pfizer’s Global Established Pharma business thereafter. Dr. Puri stayed with Pfizer, following acquisition, as President InnoPharma – a Pfizer Company, and VP of Pfizer’s Worldwide R&D, and left Pfizer in July 2015.
Dr. Puri received Smart CEO award by Future 50 magazine in Jan 2015. He was also awarded E&Y Entrepreneur of the year award from the state of NJ, in June 2015.
Dr. Puri also serves as a Director in the board of Xeris Pharmaceuticals..